With over a decade of cannabis reform advocacy with the National Organization for the Reform of Marijuana Laws (NORML), Bailey was Washington NORML’s Legislative Associate during the 2017-18 legislative sessions and the only lobbyist focused solely on recreational cannabis policy. He’s currently the consumer representative on the Washington State Liquor and Cannabis Board’s Cannabis Advisory Council and consults for regulators, licensees, and individuals. Bailey has a Bachelor of Arts in Interdisciplinary Studies from the University of Missouri-Columbia, and lives in Lacey, Washington with his wife.
In addition to planned rulemaking, the Board received an official update and public comment about the on-going issues with MJ Freeway’s traceability system.
More details on the troubled “upgrade” of MJ Freeway’s Leaf Data Systems and insight into the Board’s activity this week.
Agency leadership discussed diversity, equity, and inclusion initiatives; the lifting of the moratorium in Clark County; and an interim study on taxation by potency.
A rulemaking update, progress towards promotion of craft cannabis businesses, and a conference call on Portland’s cannabis equity grant program.
Packaging and labeling changes are revving up again, agency legislative priorities for the next session are becoming more clear, plus an overall rulemaking update.
In a successful test of an innovative meeting format, the agency gathered feedback from the regulated community on cannabis sampling, cannabis testing, and lab proficiency testing.
The Board discussed craft cannabis, representation of patient perspectives, and Portland’s equity program.
The team reviewed the first interagency meeting of the WSLCB’s Cannabis 2.0 project and assessed delays updating Washington State’s version of MJ Freeway’s Leaf Data Systems.
The Board adopted an interim policy on cannabinoid additives, heard a cannabis rulemaking timeline, and listened to public comment on the failings of the state traceability vendor, MJ Freeway.
The Board prepared to adopt a new interim policy on cannabinoid additives, discussed Cannabis 2.0, and reacted to Seattle Hempfest’s lawsuit.